NCT05756023 IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome
| NCT ID | NCT05756023 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Egymedicalpedia |
| Condition | PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries |
| Study Type | INTERVENTIONAL |
| Enrollment | 156 participants |
| Start Date | 2023-06-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 156 participants in total. It began in 2023-06-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Polycystic ovarian syndrome (PCOS) occurs in 5% to 10% of all women of reproductive age and 50% of women who present with sub-fertility due to anovulatory infertility . Clear diagnostic criteria for this condition were identified at the consensus meeting of the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine .
Eligibility Criteria
Inclusion Criteria: * Oligo-ovulation or anovulation. * Clinical and/or biochemical hyper androgenesim. * Polycystic ovaries. Exclusion Criteria: 1. Androgen-secreting tumors (ovarian or adrenal). 2. Adult-onset congenital adrenal hyperplasia. 3. Thyroid diseases. 4. Cushing's syndrome. 5. Diabetes Mellitus. 6. recurrent ICSI failure 7. endocrine, hematologic and autoimmune disorders 8. Non chromosomal and genetic abnormalities 9. Major uterine anomalies, bad surgical history, sever endometriosis, , hydrosalpinx, uterine fibroids 10. Azospermia
Contact & Investigator
Momen Kamel, Professor
STUDY CHAIR
Assiut University, Faculty of medicine, Assuit.
Frequently Asked Questions
Who can join the NCT05756023 clinical trial?
This trial is open to female participants only, aged 20 Years or older, up to 35 Years, studying PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05756023 currently recruiting?
Yes, NCT05756023 is actively recruiting participants. Contact the research team at islam.ibrahim@med.aun.edu.eg for enrollment information.
Where is the NCT05756023 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT05756023 clinical trial?
NCT05756023 is sponsored by Egymedicalpedia. The principal investigator is Momen Kamel, Professor at Assiut University, Faculty of medicine, Assuit.. The trial plans to enroll 156 participants.